Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Gallardo

Showing results (191-200 of 229) with videos related to

Pageof 23
Sort By:
Neuromuscular Disorders : NMD|October 31, 2006
Dysferlin expression in monocytes: a source of mRNA for mutation analysisN De Luna, A Freixas, P Gallano, et al.
American Journal of Human Genetics|February 15, 2001
The molecular basis of 3-methylcrotonylglycinuria, a disorder of leucine catabolismM E Gallardo, L R Desviat, J M Rodríguez, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|May 23, 2020
Latest progress in molecular biology and treatment in genitourinary tumoursA González-Del-Alba, J Á Arranz, J Bellmunt, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 22, 2013
Prospective study assessing hypoxia-related proteins as markers for the outcome of treatment with sunitinib in advanced clear-cell renal cell carcinomaJ Garcia-Donas, L J Leandro-García, A González Del Alba, et al.
The Review of Scientific Instruments|August 19, 2024
Development of improved higher-order correction for the NIF opacity spectrometerB A Hobbs, D C Mayes, R F Heeter, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 14, 2000
Phase I-II study of paclitaxel, cisplatin, and gemcitabine in advanced transitional-cell carcinoma of the urothelium. Spanish Oncology Genitourinary GroupJ Bellmunt, V Guillem, L Paz-Ares, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|April 11, 2014
Synchronous versus metachronous brain metastasis from testicular germ cell tumors (TGCT): an analysis from the Spanish Germ Cell Cancer Group data baseR Girones, J Aparicio, P Roure, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|May 11, 2019
Efficacy and safety of trifluridine/tipiracil in third-line and beyond for the treatment of patients with metastatic colorectal cancer in routine clinical practice: patterns of use and prognostic nomogramA Fernandez Montes, F Vazquez Rivera, N Martinez Lago, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 1, 2025
Enzalutamide plus radium-223 in metastatic castration-resistant prostate cancer: results of the EORTC 1333/PEACE-3 trialB Tombal, A Choudhury, F Saad, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 28, 2026
Final overall survival results from EORTC 1333/PEACE-3 trial of enzalutamide plus radium-223 in metastatic castration-resistant prostate cancerS Gillessen, E Gallardo, A Choudhury, et al.
Pageof 23

Showing results (191-200 of 229) with videos related to

Sort By:
Pageof 23
Neuromuscular Disorders : NMD|October 31, 2006
Dysferlin expression in monocytes: a source of mRNA for mutation analysisN De Luna, A Freixas, P Gallano, et al.
American Journal of Human Genetics|February 15, 2001
The molecular basis of 3-methylcrotonylglycinuria, a disorder of leucine catabolismM E Gallardo, L R Desviat, J M Rodríguez, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|May 23, 2020
Latest progress in molecular biology and treatment in genitourinary tumoursA González-Del-Alba, J Á Arranz, J Bellmunt, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 22, 2013
Prospective study assessing hypoxia-related proteins as markers for the outcome of treatment with sunitinib in advanced clear-cell renal cell carcinomaJ Garcia-Donas, L J Leandro-García, A González Del Alba, et al.
The Review of Scientific Instruments|August 19, 2024
Development of improved higher-order correction for the NIF opacity spectrometerB A Hobbs, D C Mayes, R F Heeter, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 14, 2000
Phase I-II study of paclitaxel, cisplatin, and gemcitabine in advanced transitional-cell carcinoma of the urothelium. Spanish Oncology Genitourinary GroupJ Bellmunt, V Guillem, L Paz-Ares, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|April 11, 2014
Synchronous versus metachronous brain metastasis from testicular germ cell tumors (TGCT): an analysis from the Spanish Germ Cell Cancer Group data baseR Girones, J Aparicio, P Roure, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|May 11, 2019
Efficacy and safety of trifluridine/tipiracil in third-line and beyond for the treatment of patients with metastatic colorectal cancer in routine clinical practice: patterns of use and prognostic nomogramA Fernandez Montes, F Vazquez Rivera, N Martinez Lago, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 1, 2025
Enzalutamide plus radium-223 in metastatic castration-resistant prostate cancer: results of the EORTC 1333/PEACE-3 trialB Tombal, A Choudhury, F Saad, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 28, 2026
Final overall survival results from EORTC 1333/PEACE-3 trial of enzalutamide plus radium-223 in metastatic castration-resistant prostate cancerS Gillessen, E Gallardo, A Choudhury, et al.
Pageof 23